Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 8:52:100525.
doi: 10.1016/j.ahjo.2025.100525. eCollection 2025 Apr.

Colchicine therapy in cardiovascular medicine: A literature review

Jennifer Trube  1 , Michael Sabina  1 , Aqeel Khanani  1 , Kayla Hernandez  1 , Zoya Khan  1 , Anas Bizanti  1
Affiliations
Review

Colchicine therapy in cardiovascular medicine: A literature review

Jennifer Trube et al. Am Heart J Plus. .

Abstract

Introduction: Inflammation is a key risk factor in cardiovascular diseases, such as atherosclerosis, and has been linked to increased mortality following myocardial infarction. While inflammation promotes tissue repair, sustained inflammation can drive adverse cardiac remodeling, fibrosis, and impaired contractility, resulting in poorer outcomes. This maladaptive remodeling, compounded by oxidative stress, also predisposes patients to cardiovascular diseases. Colchicine has shown anti-inflammatory benefits in cardiovascular disease, but its role in individual diseases remains unclear. This literature review seeks to understand and evaluate the clinical trials evaluating colchicine in cardiovascular treatment.

Methods: A literature search identified randomized controlled trials (RCTs) evaluating colchicine in cardiovascular disease including coronary artery disease, post-myocardial infarction treatment, atrial fibrillation, heart failure, and stroke.

Conclusions: Colchicine has been studied across many cardiovascular conditions including atrial fibrillation (AF), coronary artery disease (CAD), post-myocardial infarction treatment, heart failure (HF) and stroke; however, evidence of its clinical effectiveness remains mixed. While colchicine has shown prfomise in reducing recurrent cardiovascular events in stable CAD, its impact in postoperative AF prevention, acute coronary syndrome (ACS), HF, and stroke prevention is limited.

Keywords: Atrial fibrillation; Cardiovascular disease; Colchicine; Coronary artery disease; Heart failure.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Younas A., Awan Z., Khan T., Mehta S., Munir A., Raja H.A.A., et al. The effect of colchicine on myocardial infarction: An updated systematic review and meta-analysis of randomized controlled trials. Curr. Probl. Cardiol. 2025 Jan;50(1) - PubMed
    1. Romero-Cabrera J.L., Ankeny J., Fernández-Montero A., Kales S.N., Smith D.L. A Systematic Review and Meta-Analysis of Advanced Biomarkers for Predicting Incident Cardiovascular Disease among Asymptomatic Middle-Aged Adults. Int. J. Mol. Sci. 2022 Nov 4;23(21):13540. - PMC - PubMed
    1. Raggi P., Genest J., Giles J.T., Rayner K.J., Dwivedi G., Beanlands R.S., et al. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis. 2018 Sep;276:98–108. - PubMed
    1. Sagris M., Antonopoulos A.S., Theofilis P., Oikonomou E., Siasos G., Tsalamandris S., et al. Risk factors profile of young and older patients with myocardial infarction. Morawietz H, editor. Cardiovasc. Res. 2022 Jul 27;118(10):2281–2292. - PubMed
    1. Matter M.A., Paneni F., Libby P., Frantz S., Stähli B.E., Templin C., et al. Inflammation in acute myocardial infarction: the good, the bad and the ugly. Eur. Heart J. 2024 Jan 7;45(2):89–103. - PMC - PubMed

LinkOut - more resources